GGrantIndex
← Search

PHASE II OF ISIS 3521 IN PATIENTS WITH OVARIAN CARCINOMA

$134,676M01FY2001RRNIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →